Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
The global Liposome Drug Delivery market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Liposomal Bupivacaine
Other Liposomals
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang
CSPC
Novartis
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Liposome Drug Delivery Picture
1.1.2 Specifications
Table Product Specifications of Liposome Drug Delivery
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Liposome Drug Delivery
Table Global Liposome Drug Delivery Market by Type, 2011-2022 (USD Million)
1.2.1.1 Liposomal Doxorubicin
Table Liposomal Doxorubicin Overview
1.2.1.2 Liposomal Amphoteracin B
Table Liposomal Amphoteracin B Overview
1.2.1.3 Liposomal Paclitaxel
Table Liposomal Paclitaxel Overview
1.2.1.4 Liposomal Bupivacaine
Table Liposomal Bupivacaine Overview
1.2.1.5 Other Liposomals
Table Other Liposomals Overview
1.2.2 by Application
Table Application Segment of Liposome Drug Delivery
Table Global Liposome Drug Delivery Market by Application, 2011-2022 (USD Million)
1.2.2.1 Fungal Infection Therapy
Table Fungal Infection Therapy Overview
1.2.2.2 Cancer & Tumor Therapy
Table Cancer & Tumor Therapy Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Liposome Drug Delivery Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Liposome Drug Delivery
2.2 Upstream
Table Cost of Liposome Drug Delivery
Figure Manufacturing Process of Liposome Drug Delivery
2.3 Market
2.3.1 SWOT
Figure SWOT of Liposome Drug Delivery
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Liposome Drug Delivery
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Liposome Drug Delivery
3.4 Market Entry
Table Market Entry of Liposome Drug Delivery
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Liposomal Doxorubicin Market, 2013-2018
Figure Liposomal Doxorubicin Market Size and Growth, 2015-2019 (USD Million)
Figure Liposomal Doxorubicin Market Size and Growth, 2015-2019 (in Volume)
Table Liposomal Doxorubicin CAGR by Revenue and Volume, 2015-2019
4.1.2 Liposomal Amphoteracin B Market, 2013-2018
Figure Liposomal Amphoteracin B Market Size and Growth, 2015-2019 (USD Million)
Figure Liposomal Amphoteracin B Market Size and Growth, 2015-2019 (in Volume)
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2015-2019
4.1.3 Liposomal Paclitaxel Market, 2013-2018
Figure Liposomal Paclitaxel Market Size and Growth, 2015-2019 (USD Million)
Figure Liposomal Paclitaxel Market Size and Growth, 2015-2019 (in Volume)
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2015-2019
4.1.4 Liposomal Bupivacaine Market, 2013-2018
Figure Liposomal Bupivacaine Market Size and Growth, 2015-2019 (USD Million)
Figure Liposomal Bupivacaine Market Size and Growth, 2015-2019 (in Volume)
Table Liposomal Bupivacaine CAGR by Revenue and Volume, 2015-2019
4.1.5 Other Liposomals Market, 2013-2018
Figure Other Liposomals Market Size and Growth, 2015-2019 (USD Million)
Figure Other Liposomals Market Size and Growth, 2015-2019 (in Volume)
Table Other Liposomals CAGR by Revenue and Volume, 2015-2019
Summary: Get latest Market Research Reports on Liposome Drug Delivery . Industry analysis & Market Report on Liposome Drug Delivery is a syndicated market report, published as Liposome Drug Delivery Market Research Report 2012-2024. It is complete Research Study and Industry Analysis of Liposome Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.